StemCell Therapy

U.S. Stem Cell, Inc. is a leader in the regenerative medicine / cellular therapy industry specializing in physician training and certification and stem cell products including its lead, developmental product Adipocell, as well as veterinary stem cell training and stem cell banking and creation and management of stem cell clinics.

Forward-Looking Statements: Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "plan", "expect", "believe", "anticipate", "intend", "could", "would", "estimate", or "continue", or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements and represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements, even if new information becomes available in the future. The Company's business and the risks and uncertainties of the business are described in its filings with the Securities and Exchange Commission which can be found at sec.gov.

Media Contact: U.S. Stem Cell, Inc. 13794 NW 4th Street, Suite 212Sunrise, Fl 33325Phone: 954.835.1500Email: usstemcell@us-stemcell.com

View original content with multimedia:http://www.prnewswire.com/news-releases/us-department-of-justice-files-lawsuit-at-request-of-fda-to-stop-us-stem-cell-clinic-from-performing-autologous-stem-cell-procedure-300645973.html

SOURCE U.S. Stem Cell, Inc.

Home

See the original post here:
U.S. Department of Justice Files Lawsuit at Request of FDA ...

This entry was posted on June 20, 2018 at 6:45 pm and is filed under Stem Cell Russia. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |